IO Biotech, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IO Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • IO Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24M, a 10.8% decline year-over-year.
  • IO Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$90.4M, a 13% decline year-over-year.
  • IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$86.1M, a 20.5% decline from 2022.
  • IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$71.5M, a 5.27% decline from 2021.
  • IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$67.9M, a 464% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$86.1M -$14.6M -20.5% Jan 1, 2023 Dec 31, 2023 10-Q 2024-11-12
2022 -$71.5M -$3.58M -5.27% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$67.9M -$55.8M -464% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$12M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.